Devon Haynes

Devon Haynes

Auto-generated profile, based on publicly available information

Devon Haynes

Division of Genetics, Arnold Palmer Hospital for Children–Orlando Health, Orlando, FL, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MSMaria J. Guillen Sacoto
Maria J. Guillen Sacoto
ITIva A. Tchasovnikarova
Iva A. Tchasovnikarova
ETErin Torti
Erin Torti
CFCara Forster
Cara Forster
EAE. Hallie Andrew
E. Hallie Andrew
JJJane Juusola
Jane Juusola

16 May 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SGSara Gonçalves
Sara Gonçalves
JPJulie Patat
Julie Patat
MGMaria Clara Guida
Maria Clara Guida
NLNoelle Lachaussée
Noelle Lachaussée
CAChristelle Arrondel
Christelle Arrondel
MSMatias Simons
Matias Simons
Recent evidence suggests that the presence of more than one pathogenic mutation in a single patient is more common than previously anticipated. One of the challenges hereby is to dissect the contribution of each gene mutation, for which animal models such as Drosophila can provide a valuable aid. Here, we identified three families with mutations in ADD3, encoding for adducin-γ, with intellectual disability, microcephaly, cataracts and skeletal defects. In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in KAT2B, encoding the lysine acetyltransferase 2B, with impact on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum. In order to define the contribution of ADD3 and KAT2B mutations for the patient phenotype, we performed functional experiments in the Drosophila model. We found that both mutations were unable to fully rescue the viability of the respective null mutants of the Drosophila homologs, hts and Gcn5, suggesting that they are indeed pathogenic in flies. While the KAT2B/Gcn5 mutation additionally showed a significantly reduced ability to rescue morphological and functional defects of cardiomyocytes and nephrocytes (podocyte-like cells), this was not the case for the ADD3 mutant rescue. Yet, the simultaneous knockdown of KAT2B and ADD3 synergistically impaired kidney and heart function in flies as well as the adhesion and migration capacity of cultured human podocytes, indicating that mutations in both genes may be required for the full clinical manifestation. Altogether, our studies describe the expansion of the phenotypic spectrum in ADD3 deficiency associated with a homozygous likely pathogenic KAT2B variant and thereby identify KAT2B as a susceptibility gene for kidney and heart disease in ADD3-associated disorders. Genetic diseases with complex syndromic constellations may be caused by mutations in more than one gene. Most examples studied so far describe genetic interactions of known disease genes, suggesting that a large number of multilocus diseases remain unexplored. Assessment of mutation pathogenicity can be achieved using animal models. One main advantage of using Drosophila is that it allows easy in vivo gene manipulation in cell types that are relevant for the disease. Here, we report the pathogenicity of ADD3 mutations in three families with intellectual disability, microcephaly, cataracts and skeletal defects. Moreover, we provide evidence that the renal and cardiac phenotypes in one of the families could be unmasked by a homozygous variant in the lysine acetyltransferase encoding KAT2B gene. In Drosophila, this variant resulted not only in decreased viability, but also in functional defects in cardiomyocytes and nephrocytes, the latter being similar to mammalian podocytes. Our study implicates KAT2B as a susceptibility gene for steroid-resistant nephrotic syndrome (SRNS) and cardiomyopathy and emphasizes the importance of protein acetylation in kidney and heart function.

31 January 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
KGKevin E. Glinton
Kevin E. Glinton
AHAnna CE Hurst
Anna CE Hurst
KBKevin M. Bowling
Kevin M. Bowling
ICIngrid Cristian
Ingrid Cristian
DHDevon Haynes
Devon Haynes
PSPawel Stankiewicz
Pawel Stankiewicz
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL), defined primarily by developmental delay/intellectual disability, speech delay, postnatal microcephaly, and dysmorphic features, is a syndrome resulting from heterozygous variants in the dosage‐sensitive bromodomain PHD finger chromatin remodeler transcription factor BPTF gene. To date, only 11 individuals with NEDDFL due to de novo BPTF variants have been described. To expand the NEDDFL phenotypic spectrum, we describe the clinical features in 25 novel individuals with 20 distinct, clinically relevant variants in BPTF, including four individuals with inherited changes in BPTF. In addition to the previously described features, individuals in this cohort exhibited mild brain abnormalities, seizures, scoliosis, and a variety of ophthalmologic complications. These results further support the broad and multi‐faceted complications due to haploinsufficiency of BPTF.

10 March 2023 in Science Advances
Verified
Journal Article
Closed access
SSSarah E. Sheppard
Sarah E. Sheppard
LBLaura Bryant
Laura Bryant
RWRochelle Wickramasekara
Rochelle Wickramasekara
CVCourtney Vaccaro
Courtney Vaccaro
BRBrynn Robertson
Brynn Robertson
HSHolly Stessman
Holly Stessman
Pathogenic variants in KMT5B , a lysine methyltransferase, are associated with global developmental delay, macrocephaly, autism, and congenital anomalies (OMIM # 617788). Given the relatively recent discovery of this disorder, it has not been fully characterized. Deep phenotyping of the largest ( n = 43) patient cohort to date identified that hypotonia and congenital heart defects are prominent features that were previously not associated with this syndrome. Both missense variants and putative loss-of-function variants resulted in slow growth in patient-derived cell lines. KMT5B homozygous knockout mice were smaller in size than their wild-type littermates but did not have significantly smaller brains, suggesting relative macrocephaly, also noted as a prominent clinical feature. RNA sequencing of patient lymphoblasts and Kmt5b haploinsufficient mouse brains identified differentially expressed pathways associated with nervous system development and function including axon guidance signaling. Overall, we identified additional pathogenic variants and clinical features in KMT5B -related neurodevelopmental disorder and provide insights into the molecular mechanisms of the disorder using multiple model systems.

23 April 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
DHDevon Haynes
Devon Haynes
LPLynda Pollack
Lynda Pollack
CPChitra Prasad
Chitra Prasad
SGSharan Goobie
Sharan Goobie
SCSamantha Colaiacovo
Samantha Colaiacovo
YLYves Lacassie
Yves Lacassie

26 October 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SGSara Gonçalves
Sara Gonçalves
JPJulie Patat
Julie Patat
MGMaria Clara Guida
Maria Clara Guida
NLNoelle Lachaussée
Noelle Lachaussée
CAChristelle Arrondel
Christelle Arrondel
MSMatias Simons
Matias Simons
[This corrects the article DOI: 10.1371/journal.pgen.1007386.].